EUVIMEDOpdag EUVIMED
Crossref

Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy

Chengcheng Xu, Yao Wu, Lili Tang, Yan Liang, Yang Zhao iD

Biotechnology and Applied Biochemistry · 2023-02 · 70 (1) · 268-280

DOI: 10.1002/bab.2350 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, published online on 2022-05-05. Written by Chengcheng Xu and 4 co-authors. Institution: Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Major MEDLINE topics: Parkinson Disease, MPTP Poisoning, Neuroprotective Agents. Cited 17 times so far (Crossref); 32 references. Funded by: Jiangsu Province TCM Leading Talents Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

One of the main pathological features of Parkinson's disease (PD) is the loss of dopaminergic neurons in the substantia nigra compacta (SNc). Cistanoside A (CA) has a strong neuroprotective effect in PD, but the exact mechanism is unclear. In the present study, the MPTP‐stimulated mouse model of PD and MPP + ‐treated PD model in the MES23.5 neuronal cell model of PD were used to investigate the neuroprotective effects of CA on PD and its potential mechanism. The in vivo experiment results indicated that CA improved the motor function in mice and increased the number of tyrosine hydroxylase positive cells in SNc. In vitro experiments showed that CA reduced the MPP + ‐induced decrease in neurons and mitochondrial membrane potential and promoted the activation of autophagosomes. Furthermore, we found that CA promoted the recruitment of PINK1 and Parkin aggregation to impair mitochondrial membranes and inhibited mitochondrial damage via LC3‐ and p62‐mediated autophagy. In conclusion, CA protects against MPTP‐induced neurotoxicity in vivo and MPP + ‐induced neurotoxicity in vitro, possibly by promoting the PINK1/Parkin/p62 pathway to accelerate the degradation of damaged mitochondria thereby reducing oxidative stress.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseMPTP PoisoningNeuroprotective AgentsMiceAnimalsDopaminergic NeuronsMitophagyUbiquitin-Protein LigasesProtein KinasesMice, Inbred C57BLCatecholsGlycosides

Author keywords

MPTP/MPP+PINK1/ParkinParkinson's diseasecistanoside Adopaminergic neurons

Substances

Neuroprotective AgentsUbiquitin-Protein LigasesProtein Kinasescistanoside ACatecholsGlycosides

Authors and institutions

  • Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

ORCID profiles: Yang Zhao

Funding

  • Jiangsu Province TCM Leading Talents Project

Cite

APA

Xu, C., Wu, Y., Tang, L., Liang, Y., & Zhao, Y. (2023). Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy. Biotechnology and Applied Biochemistry, 70(1), 268-280. https://doi.org/10.1002/bab.2350

Vancouver

Xu C, Wu Y, Tang L, Liang Y, Zhao Y. Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy. Biotechnology and Applied Biochemistry. 2023;70(1):268-280. doi:10.1002/bab.2350

BibTeX
@article{Xu2023,
  author = {Xu, Chengcheng and Wu, Yao and Tang, Lili and Liang, Yan and Zhao, Yang},
  title = {Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2023},
  volume = {70},
  number = {1},
  pages = {268--280},
  doi = {10.1002/bab.2350}
}
Start for free →